{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T06:56:19Z","timestamp":1649141779668},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/inf.0b013e31828745b2","type":"journal-article","created":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T17:26:25Z","timestamp":1359739585000},"page":"556-557","source":"Crossref","is-referenced-by-count":2,"title":["Update on Antifungal Resistance in Children"],"prefix":"10.1097","volume":"32","author":[{"given":"Paul E.","family":"Verweij","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adilia","family":"Warris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-24-20210202","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin Study Group. Anidulafungin versus fluconazole for invasive candidiasis.","volume":"356","author":"Reboli","year":"2007","journal-title":"N Engl J Med"},{"key":"R2-24-20210202","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.diagmicrobio.2010.06.015","article-title":"Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009).","volume":"68","author":"Pfaller","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R3-24-20210202","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1128\/JCM.05474-11","article-title":"Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey.","volume":"49","author":"Peman","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R4-24-20210202","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/INF.0b013e3182737427","article-title":"International Pediatric Fungal Network. Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates.","volume":"31","author":"Steinbach","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R5-24-20210202","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/13693780802262123","article-title":"Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.","volume":"47","author":"Ikeda","year":"2009","journal-title":"Med Mycol"},{"key":"R6-24-20210202","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1111\/1469-0691.12040","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: Prevention and management of invasive infections in neonates and children caused by Candida spp.","volume":"18","author":"Hope","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R8-24-20210202","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R9-24-20210202","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/JCM.02390-09","article-title":"Breakthrough invasive candidiasis in patients on micafungin.","volume":"48","author":"Pfeiffer","year":"2010","journal-title":"J Clin Microbiol"},{"key":"R10-24-20210202","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.05088-11","article-title":"Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature.","volume":"56","author":"Camps","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"R11-24-20210202","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.","volume":"15","author":"Howard","year":"2009","journal-title":"Emerging Infect Dis"},{"key":"R13-24-20210202","doi-asserted-by":"crossref","first-page":"e31801","DOI":"10.1371\/journal.pone.0031801","article-title":"Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus.","volume":"7","author":"Snelders","year":"2012","journal-title":"PLoS ONE"},{"key":"R14-24-20210202","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1056\/NEJM200212263472618","article-title":"Multidrug resistance in Aspergillus fumigatus.","volume":"347","author":"Warris","year":"2002","journal-title":"N Engl J Med"},{"key":"R15-24-20210202","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13693780802545600","article-title":"Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery.","volume":"47","author":"Hodiamont","year":"2009","journal-title":"Med Mycol"},{"key":"R16-24-20210202","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/597465","article-title":"Azole-resistant central nervous system aspergillosis.","volume":"48","author":"van der Linden","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R17-24-20210202","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009.","volume":"17","author":"van der Linden","year":"2011","journal-title":"Emerging Infect Dis"},{"key":"R18-24-20210202","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/jac\/dks402","article-title":"Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis.","volume":"68","author":"Seyedmousavi","year":"2013","journal-title":"J Antimicrob Chemother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0b013e31828745b2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:09:36Z","timestamp":1620954576000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201305000-00024"}},"subtitle":["Epidemiology and Recommendations"],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31828745b2","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}